Cognition Therapeutics Inc’s recent filing unveils that its CEO & President Ricciardi Lisa acquired Company’s shares for reported $30001.0 on Jan 31 ’25. In the deal valued at $0.77 per share,38,851 shares were bought. As a result of this transaction, Ricciardi Lisa now holds 38,851 shares worth roughly $24476.13.
Then, Ricciardi Lisa bought 5,700 shares, generating $9,975 in total proceeds. Upon buying the shares at $1.75, the CEO & President now owns 291,345 shares.
B. Riley Securities upgraded its Cognition Therapeutics Inc [CGTX] rating to a Buy from a a Neutral in a research note published on December 19, 2024; the price target was increased to $1.50 from $1. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in late July from “an Overweight” to “a Neutral”. Oppenheimer began covering CGTX with “an Outperform” recommendation on November 03, 2021. B. Riley Securities started covering the stock on November 03, 2021. It rated CGTX as “a Buy”.
Price Performance Review of CGTX
On Tuesday, Cognition Therapeutics Inc [NASDAQ:CGTX] saw its stock fall -5.71% to $0.63. Over the last five days, the stock has lost -17.25%. Cognition Therapeutics Inc shares have fallen nearly -10.45% since the year began. Nevertheless, the stocks have fallen -72.58% over the past one year. While a 52-week high of $2.95 was reached on 01/06/25, a 52-week low of $0.34 was recorded on 02/04/25. SMA at 50 days reached $0.6125, while 200 days put it at $1.0702.
Levels Of Support And Resistance For CGTX Stock
The 24-hour chart illustrates a support level at 0.5900, which if violated will result in even more drops to 0.5500. On the upside, there is a resistance level at 0.6800. A further resistance level may holdings at 0.7300. The Relative Strength Index (RSI) on the 14-day chart is 41.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0519, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.05%. Stochastics %K at 21.52% indicates the stock is a holding.
How much short interest is there in Cognition Therapeutics Inc?
A steep rise in short interest was recorded in Cognition Therapeutics Inc stocks on 2024-10-31, growing by 0.28 million shares to a total of 0.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.53 million shares. There was a rise of 34.85%, which implies that there is a positive sentiment for the stock.
